Paper10775615
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
Ikeda K and 6 others. J Virol, 2000. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. Papers, record 10775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10775615
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Complement System Proteins | Major topic |
| Glioma | Major topic |
| Simplexvirus | Major topic |
| Adenoviridae | |
| Animals | |
| Brain | |
| Complement Inactivator Proteins | |
| Cyclophosphamide | |
| Elapid Venoms | |
| Female | |
| Gene Transfer Techniques | |
| Genetic Vectors | |
| Herpes Simplex | |
| Humans | |
| Immunosuppressive Agents | |
| Mutation | |
| Rats | |
| Rats, Nude | |
| Virus Activation | |
| Virus Replication |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA069246 | NCI NIH HHS | United States | P01CA069246 | PubMed and NIH |
| CA 69246 | NCI NIH HHS | United States | P01CA069246 | PubMed and NIH |
Source NIH RePORTER
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,212,547 | A cosmid-based system for constructing mutants of herpes simplex virus type 1. | Virology | 1993 | https://conductscience.org/library/papers/8212547 | PubMed |
| 2 | 7,511,171 | Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. | J Virol | 1994 | https://conductscience.org/library/papers/7511171 | PubMed |
| 3 | 8,186,298 | Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. | Hum Gene Ther | 1994 | https://conductscience.org/library/papers/8186298 | PubMed |
| 4 | 8,040,891 | Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. | J Natl Cancer Inst | 1994 | https://conductscience.org/library/papers/8040891 | PubMed |
| 5 | 7,954,393 | Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954393 | PubMed |
| 6 | 7,954,437 | Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954437 | PubMed |
| 7 | 7,877,992 | Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7877992 | PubMed |
| 8 | 7,568,227 | Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7568227 | PubMed |
| 9 | 7,584,098 | Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. | Gene Ther | 1994 | https://conductscience.org/library/papers/7584098 | PubMed |
| 10 | 7,474,937 | Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. | Lab Invest | 1995 | https://conductscience.org/library/papers/7474937 | PubMed |
| 11 | 8,525,509 | Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. | Transplantation | 1995 | https://conductscience.org/library/papers/8525509 | PubMed |
| 12 | 8,664,379 | Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. | Hum Gene Ther | 1995 | https://conductscience.org/library/papers/8664379 | PubMed |
| 13 | 8,676,446 | Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. | J Virol | 1996 | https://conductscience.org/library/papers/8676446 | PubMed |
| 14 | 8,693,522 | Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts. | Transplantation | 1996 | https://conductscience.org/library/papers/8693522 | PubMed |
| 15 | 8,779,679 | Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. | Transplantation | 1996 | https://conductscience.org/library/papers/8779679 | PubMed |
| 16 | 8,812,155 | Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. | Exp Neurol | 1996 | https://conductscience.org/library/papers/8812155 | PubMed |
| 17 | 8,832,876 | An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. | Science | 1996 | https://conductscience.org/library/papers/8832876 | PubMed |
| 18 | 8,895,767 | A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. | Cancer Res | 1996 | https://conductscience.org/library/papers/8895767 | PubMed |
| 19 | 8,912,895 | Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. | Exp Neurol | 1996 | https://conductscience.org/library/papers/8912895 | PubMed |
| 20 | 8,990,354 | Apyrase administration prolongs discordant xenograft survival. | Transplantation | 1996 | https://conductscience.org/library/papers/8990354 | PubMed |
Cited by88
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,652,085 | Complement-Targeted Therapies in Glioblastoma: A Systematic Review. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652085 | PubMed |
| 42,032,342 | Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42032342 | PubMed |
| 40,849,827 | Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40849827 | PubMed |
| 40,555,086 | Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges. | Semin Immunol | 2025 | https://conductscience.org/library/papers/40555086 | PubMed |
| 40,143,547 | Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation. | Mol Ther | 2025 | https://conductscience.org/library/papers/40143547 | PubMed |
| 39,741,405 | Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus development. | Mol Ther | 2025 | https://conductscience.org/library/papers/39741405 | PubMed |
| 39,710,201 | Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery. | World Neurosurg | 2025 | https://conductscience.org/library/papers/39710201 | PubMed |
| 39,504,364 | Heterogeneous multiple soft millirobots in three-dimensional lumens. | Sci Adv | 2024 | https://conductscience.org/library/papers/39504364 | PubMed |
| 39,239,066 | Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39239066 | PubMed |
| 38,169,820 | Oncolytic virotherapy in cancer treatment: challenges and optimization prospects. | Front Immunol | 2023 | https://conductscience.org/library/papers/38169820 | PubMed |
| 38,150,172 | Personalizing Oncolytic Immunovirotherapy Approaches. | Mol Diagn Ther | 2024 | https://conductscience.org/library/papers/38150172 | PubMed |
| 36,835,091 | The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835091 | PubMed |
| 36,631,681 | Therapy with oncolytic viruses: progress and challenges. | Nat Rev Clin Oncol | 2023 | https://conductscience.org/library/papers/36631681 | PubMed |
| 36,148,235 | Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study. | Front Immunol | 2022 | https://conductscience.org/library/papers/36148235 | PubMed |
| 35,062,322 | Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors. | Viruses | 2022 | https://conductscience.org/library/papers/35062322 | PubMed |
| 34,452,439 | The Multifaceted Role of Macrophages in Oncolytic Virotherapy. | Viruses | 2021 | https://conductscience.org/library/papers/34452439 | PubMed |
| 33,981,827 | Efficient delivery of oncolytic enterovirus by carrier cell line NK-92. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/33981827 | PubMed |
| 32,373,649 | Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/32373649 | PubMed |
| 31,312,139 | Gene Therapy Tools for Brain Diseases. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31312139 | PubMed |
| 31,243,134 | Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum. | J Virol | 2019 | https://conductscience.org/library/papers/31243134 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10775615
GET https://conductscience.org/api/papers/v1/10775615/references?page=2